N. Mahroum Et Al. , "Higher rates of COVID-19 but less severe infections reported for patients on Dupilumab: A big data analysis of the World Health Organization VigiBase," European Review for Medical and Pharmacological Sciences , vol.25, no.18, pp.5865-5870, 2021
Mahroum, N. Et Al. 2021. Higher rates of COVID-19 but less severe infections reported for patients on Dupilumab: A big data analysis of the World Health Organization VigiBase. European Review for Medical and Pharmacological Sciences , vol.25, no.18 , 5865-5870.
Mahroum, N., Damiani, G., Watad, A., Amital, H., Bragazzi, N. L., Farah, R., ... Wu, J.(2021). Higher rates of COVID-19 but less severe infections reported for patients on Dupilumab: A big data analysis of the World Health Organization VigiBase. European Review for Medical and Pharmacological Sciences , vol.25, no.18, 5865-5870.
Mahroum, N. Et Al. "Higher rates of COVID-19 but less severe infections reported for patients on Dupilumab: A big data analysis of the World Health Organization VigiBase," European Review for Medical and Pharmacological Sciences , vol.25, no.18, 5865-5870, 2021
Mahroum, N. Et Al. "Higher rates of COVID-19 but less severe infections reported for patients on Dupilumab: A big data analysis of the World Health Organization VigiBase." European Review for Medical and Pharmacological Sciences , vol.25, no.18, pp.5865-5870, 2021
Mahroum, N. Et Al. (2021) . "Higher rates of COVID-19 but less severe infections reported for patients on Dupilumab: A big data analysis of the World Health Organization VigiBase." European Review for Medical and Pharmacological Sciences , vol.25, no.18, pp.5865-5870.
@article{article, author={N. Mahroum Et Al. }, title={Higher rates of COVID-19 but less severe infections reported for patients on Dupilumab: A big data analysis of the World Health Organization VigiBase}, journal={European Review for Medical and Pharmacological Sciences}, year=2021, pages={5865-5870} }